Healthcare Professionals
Attesta™
Pacing System for Bradyarrhythmia Management.
Model #: ATDRL1, ATSR01
You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this webpage is exclusively reserved for registered medical practitioners.
Click “OK” to confirm you are a registered medical practitioner.
Healthcare Professionals
Attesta™
Pacing System for Bradyarrhythmia Management.
Model #: ATDRL1, ATSR01
Full suite of automaticity features that adjust and adapt to deliver therapy to meet the patient's needs while optimising current drain and maximising longevity.
Clinically proven Managed Ventricular Pacing (MVP) algorithm promotes intrinsic conduction and reduces unnecessary RV pacing by 99% leading to reduced risk of AF and HF hospitalisation.1
Medtronic SureScan™ MRI devices are built to be scanned and allow more patients access to better disease diagnostics. Ensure your patients get 1.5T and 3T MRI scans with simple scanning conditions, in any combination of Medtronic MRI compatible devices and leads, when conditions are met.
Gillis AM, Pürerfellner H, Israel CW, et al. Reduction of unnecessary ventricular pacing due to the Managed Ventricular Pacing (MVP) mode in pacemaker patients: Benefit for both sinus node disease (SND) and AV block (AVB) indications. Heart Rhythm. 2005;Abstract AB21-1.